scholarly article | Q13442814 |
P356 | DOI | 10.1086/508865 |
P8608 | Fatcat ID | release_fj7hajm5nzgphjbhdd2wfpmgam |
P698 | PubMed publication ID | 17109297 |
P50 | author | Max Essex | Q6794729 |
Sikhulile Moyo | Q56990380 | ||
Tendani Gaolathe | Q91908938 | ||
Ndwapi Ndwapi | Q92727538 | ||
P2093 | author name string | Ava Avalos | |
C William Wester | |||
Hermann Bussmann | |||
Richard G Marlink | |||
Rob Roy MacGregor | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Botswana | Q963 |
P304 | page(s) | 1612-1615 | |
P577 | publication date | 2006-11-08 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana | |
P478 | volume | 43 |
Q37415603 | Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges |
Q35744193 | Cancer Incidence following Expansion of HIV Treatment in Botswana |
Q55030278 | Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana. |
Q64111522 | Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes |
Q35183973 | HIV, Hepatitis B, and Hepatitis C in Zambia |
Q40794632 | Hepatitis B vaccination of healthcare workers at the Princess Marina Hospital, Botswana |
Q37792614 | Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis |
Q42698618 | High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana |
Q37141399 | Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen |
Q64360047 | Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries |
Q34189873 | Importance of nonenteric protozoan infections in immunocompromised people. |
Q58726310 | In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm |
Q89970158 | Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana |
Q40797865 | Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana |
Q57159588 | Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana |
Q35744379 | Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana |
Q35282729 | Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting |
Q36131256 | Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients |
Q34982182 | Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya |
Q35131468 | Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana |
Q38963371 | Reliability of rapid testing for hepatitis B in a region of high HIV endemicity |
Q38974815 | Review of cytomegalovirus coinfection in HIV-infected individuals in Africa |
Q37375386 | Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana |
Search more.